Coronavirus Update:What patients and families need to know
Sheikh Zayed Institute has a wealth of collaborative initiatives and programs designed to improve care for children. Its Second Annual Symposium on Pediatric Surgical Innovation brought together leaders, and advocates of pediatric surgical and device innovation to form consensus and achievable tasks to accomplish its mission. Its targeted areas of care, from fetal and translational medicine, to heart, and blood transplantation, and its links with academic institutions universities enable it to achieve its goals.
The Sheikh Zayed Institute’s investigators collaborate with the Gilbert Family Neurofibromatosis Institute, one of the largest neurofibromatosis programs in the world that leads in the diagnosis, evaluation, and treatment of children and adults with all the conditions that relate to this disorder.
In collaboration with its small businesses partners, the Sheikh Zayed Institute was the recipient of the following three additional SBIR/STTR Phase I funding from the NIH National Institute on Minority Health and Health Disparities; the NIH National Institute of Child Health and Human Development, and the NIH National Cancer Institute. The awardees included investigators Zenaide Quezado, MD, Marius Linguraru, DPhil, and Raj Shekhar, PhD.
The seed funding program to boost collaboration between researchers at the University of Maryland A. James Clark School of Engineering and the Sheikh Zayed Institute for Pediatric Surgical Innovation, established in 2013, led to over 10 joint intellectual property fillings, and an impressive number of joint publications and grant submissions.
For the second year in a row, Sheikh Zayed Institute entrepreneurs got accepted into the I-Corps program and benefited from a curriculum taught by successful technology entrepreneurs. Each participating team talked to a minimum of one hundred customers, partners, competitors, and other market stakeholders.
Adré J. du Plessis, MBChB, MD, Chief of Fetal and Transitional Medicine at Children’s National, joined the Sheikh Zayed Institute to develop non-invasive continuous neuromonitoring techniques and validate novel biomarkers of imminent brain injury.
Brian Reilly, MD, of Otolaryngology, a new member of the Sheikh Zayed Institute, is working with the Institute's engineers to develop an ear tube made of a biocompatible material that can retain its form and function in physiological conditions and quickly dissolve on contact with uniquely formulated ear drops. This new approach will reduce follow up surgeries for removing ear tubes.